Subclinical retinopathy in systemic lupus erythematosus patients – optical coherence tomography study

Introduction The aim was to detect subclinical structural retinal abnormalities in optical coherence tomography (OCT) in ophthalmologically asymptomatic systemic lupus erythematosus (SLE) patients without signs of lupus retinopathy or drug toxicity in fundus examination and in OCT and to assess the...

Full description

Bibliographic Details
Main Authors: Małgorzata Karolina Mimier-Janczak, Dorota Kaczmarek, Krzysztof Proc, Marta Misiuk-Hojło, Radosław Kaczmarek
Format: Article
Language:English
Published: Termedia Publishing House 2023-06-01
Series:Rheumatology
Subjects:
Online Access:https://reu.termedia.pl/Subclinical-retinopathy-in-systemic-lupus-erythematosus-patients-optical-coherence,166296,0,2.html
_version_ 1827620174956593152
author Małgorzata Karolina Mimier-Janczak
Dorota Kaczmarek
Krzysztof Proc
Marta Misiuk-Hojło
Radosław Kaczmarek
author_facet Małgorzata Karolina Mimier-Janczak
Dorota Kaczmarek
Krzysztof Proc
Marta Misiuk-Hojło
Radosław Kaczmarek
author_sort Małgorzata Karolina Mimier-Janczak
collection DOAJ
description Introduction The aim was to detect subclinical structural retinal abnormalities in optical coherence tomography (OCT) in ophthalmologically asymptomatic systemic lupus erythematosus (SLE) patients without signs of lupus retinopathy or drug toxicity in fundus examination and in OCT and to assess the relationship between OCT parameters and disease activity, therapy type and burden on other organs to demonstrate the utility of OCT in early retinal impairment in SLE patients. Material and methods Cross-sectional study. Thirty-three SLE patients (57 eyes) and 31 healthy individuals (56 eyes) were enrolled in the study. We excluded patients with evidence of lupus retinopathy or hydroxychloroquine (HCQ) toxicity on OCT or fundus examination to reveal any subclinical changes. All patients underwent full ophthalmologic examination in the slit lamp including best corrected visual acuity, tonometry, and OCT. The Kolmogorov-Smirnov distribution test was used to assess the normal distribution in quantitative values. The differences between the individual measured parameters in the groups were analyzed using the Mann-Whitney U test. Spearman’s rank correlation test was used to assess the correlation between the measured parameters and quantitative clinical data. Results There was no difference in the OCT findings between SLE and healthy control groups. Among the study group a negative correlation was found between disease duration and age and retinal nerve fiber layer thickness in the inferior quadrant ( p = 0.0063, p = 0.0036). No correlations were observed between examined retinal parameters and duration of hydroxychloroquine therapy, hydroxychloroquine as well as chloroquine cumulative dose and disease activity indices. Conclusions Optical coherence tomography is a widespread ophthalmic modality used for SLE retinopathy and HCQ toxicity screening. Our study did not demonstrate its clinical potency in diagnosis of subclinical retinal involvement. An optical coherence tomography device seems to be less sensitive in subclinical retinal impairment detection than optical coherence tomography angiography.
first_indexed 2024-03-09T10:43:58Z
format Article
id doaj.art-d794b1fc89d74e0392c45efdcbf13935
institution Directory Open Access Journal
issn 0034-6233
2084-9834
language English
last_indexed 2024-03-09T10:43:58Z
publishDate 2023-06-01
publisher Termedia Publishing House
record_format Article
series Rheumatology
spelling doaj.art-d794b1fc89d74e0392c45efdcbf139352023-12-01T12:03:28ZengTermedia Publishing HouseRheumatology0034-62332084-98342023-06-0161316116810.5114/reum/166296166296Subclinical retinopathy in systemic lupus erythematosus patients – optical coherence tomography studyMałgorzata Karolina Mimier-Janczak0https://orcid.org/0000-0002-7740-2951Dorota Kaczmarek1Krzysztof Proc2Marta Misiuk-Hojło3Radosław Kaczmarek4Department and Clinic of Ophthalmology, Wroclaw Medical University, PolandOphthalmology Clinical Centre Spektrum, Wroclaw, PolandDepartment of Rheumatology and Internal Medicine, Wroclaw Medical University, PolandDepartment and Clinic of Ophthalmology, Wroclaw Medical University, PolandDepartment and Clinic of Ophthalmology, Wroclaw Medical University, PolandIntroduction The aim was to detect subclinical structural retinal abnormalities in optical coherence tomography (OCT) in ophthalmologically asymptomatic systemic lupus erythematosus (SLE) patients without signs of lupus retinopathy or drug toxicity in fundus examination and in OCT and to assess the relationship between OCT parameters and disease activity, therapy type and burden on other organs to demonstrate the utility of OCT in early retinal impairment in SLE patients. Material and methods Cross-sectional study. Thirty-three SLE patients (57 eyes) and 31 healthy individuals (56 eyes) were enrolled in the study. We excluded patients with evidence of lupus retinopathy or hydroxychloroquine (HCQ) toxicity on OCT or fundus examination to reveal any subclinical changes. All patients underwent full ophthalmologic examination in the slit lamp including best corrected visual acuity, tonometry, and OCT. The Kolmogorov-Smirnov distribution test was used to assess the normal distribution in quantitative values. The differences between the individual measured parameters in the groups were analyzed using the Mann-Whitney U test. Spearman’s rank correlation test was used to assess the correlation between the measured parameters and quantitative clinical data. Results There was no difference in the OCT findings between SLE and healthy control groups. Among the study group a negative correlation was found between disease duration and age and retinal nerve fiber layer thickness in the inferior quadrant ( p = 0.0063, p = 0.0036). No correlations were observed between examined retinal parameters and duration of hydroxychloroquine therapy, hydroxychloroquine as well as chloroquine cumulative dose and disease activity indices. Conclusions Optical coherence tomography is a widespread ophthalmic modality used for SLE retinopathy and HCQ toxicity screening. Our study did not demonstrate its clinical potency in diagnosis of subclinical retinal involvement. An optical coherence tomography device seems to be less sensitive in subclinical retinal impairment detection than optical coherence tomography angiography.https://reu.termedia.pl/Subclinical-retinopathy-in-systemic-lupus-erythematosus-patients-optical-coherence,166296,0,2.htmloptical coherence tomographysystemic lupus erythematosussubclinical retinal diseaseoccult eye involvement
spellingShingle Małgorzata Karolina Mimier-Janczak
Dorota Kaczmarek
Krzysztof Proc
Marta Misiuk-Hojło
Radosław Kaczmarek
Subclinical retinopathy in systemic lupus erythematosus patients – optical coherence tomography study
Rheumatology
optical coherence tomography
systemic lupus erythematosus
subclinical retinal disease
occult eye involvement
title Subclinical retinopathy in systemic lupus erythematosus patients – optical coherence tomography study
title_full Subclinical retinopathy in systemic lupus erythematosus patients – optical coherence tomography study
title_fullStr Subclinical retinopathy in systemic lupus erythematosus patients – optical coherence tomography study
title_full_unstemmed Subclinical retinopathy in systemic lupus erythematosus patients – optical coherence tomography study
title_short Subclinical retinopathy in systemic lupus erythematosus patients – optical coherence tomography study
title_sort subclinical retinopathy in systemic lupus erythematosus patients optical coherence tomography study
topic optical coherence tomography
systemic lupus erythematosus
subclinical retinal disease
occult eye involvement
url https://reu.termedia.pl/Subclinical-retinopathy-in-systemic-lupus-erythematosus-patients-optical-coherence,166296,0,2.html
work_keys_str_mv AT małgorzatakarolinamimierjanczak subclinicalretinopathyinsystemiclupuserythematosuspatientsopticalcoherencetomographystudy
AT dorotakaczmarek subclinicalretinopathyinsystemiclupuserythematosuspatientsopticalcoherencetomographystudy
AT krzysztofproc subclinicalretinopathyinsystemiclupuserythematosuspatientsopticalcoherencetomographystudy
AT martamisiukhojło subclinicalretinopathyinsystemiclupuserythematosuspatientsopticalcoherencetomographystudy
AT radosławkaczmarek subclinicalretinopathyinsystemiclupuserythematosuspatientsopticalcoherencetomographystudy